Advanced Proteome Therapeutics Provides Update

2024-07-19T22:18:14-04:00

Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to announce that it’s US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”), is rapidly advancing two projects with the near-term potential to add significant shareholder value.